NCT01512186
A Phase II Study Investigating Upfront Pazopanib In Metastatic Renal Cancer Renal Cancer (Panther) No drug interventions Not Available Not Available unknown_status NCT01714765
Dose Escalation Study Investigating Everolimus and Dovitinib in Metastatic Clear Cell Renal Cancer treatment 1 completed NCT02035358
Immunotherapy Study for Metastatic Renal Cell Cancer No drug interventions treatment 1 completed NCT05753839
The Role of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma in Immuno-oncology Era: SEVURO-CN Trial No drug interventions treatment Not Available recruiting NCT05698238
Clinical Study to Evaluate Safety and Dosing of CA9hu-1 in Patients With Advanced Solid Tumours No drug interventions treatment 1 not_yet_recruiting NCT06389682
Pharmacokinetics, Biodistribution, Radiation Dose and Safety Study of 68Ga-NYM005 in Patients No drug interventions diagnostic 1 recruiting NCT05363631
Seleno-L Methionine (SLM)-Axitinib-Pembrolizumab treatment 1 / 2 recruiting NCT02019576
Stereotactic Radiotherapy for Metastatic Kidney Cancer Being Treated With Sunitinib No drug interventions treatment 2 completed NCT02960906
A BIOmarker Driven Trial With Nivolumab and Ipilimumab or VEGFR tKi in Naïve Metastatic Kidney Cancer treatment 2 completed NCT04904302
Sitravatinib and Nivolumab for the Treatment of Metastatic or Advanced Clear Cell Renal Cell Cancer treatment 2 active_not_recruiting NCT04370509
Pembrolizumab With or Without Axitinib for Treatment of Locally Advanced or Metastatic Clear Cell Kidney Cancer in Patients Undergoing Surgery treatment 2 recruiting NCT05012371
Lenvatinib with Everolimus Versus Cabozantinib for Second-Line or Third-Line Treatment of Metastatic Renal Cell Cancer treatment 2 active_not_recruiting NCT06349642
Predicting Response to Immune Checkpoint Inhibitors Across Solid Tumors Using a Live Tumor Diagnostic Platform No drug interventions Not Available Not Available recruiting NCT02848768
Validation of a Predictive Nomogram of Response or Resistance to Targeted Therapies in Metastatic Clear Cell Renal Cell Carcinoma Not Available Not Available completed NCT06361810
PSMA Therapy and Immunotherapy in Kidney Cancer treatment 1 / 2 not_yet_recruiting NCT06059014
Phase I/II Study Evaluating PSMA Targeted Radionuclide Therapy in Adult Patients With Metastatic Clear Cell Renal Cancer treatment 1 / 2 recruiting NCT06428708
[18F] PSMA-1007 PET/CT in Metastatic Clear Cell Renal Cell Carcinoma No drug interventions diagnostic 0 recruiting NCT04510597
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial No drug interventions treatment 3 recruiting NCT05879471
68Ga-NY104 PET/CT in Patients With Metastatic Clear Cell Renal Cell Carcinoma No drug interventions diagnostic 2 recruiting NCT01896271
High Dose IL-2 and Stereotactic Ablative Body Radiation Therapy for Metastatic Renal Cancer No drug interventions treatment 2 completed NCT03334409
Pazopanib Hydrochloride With or Without Ascorbic Acid in Treating Patients With Kidney Cancer That Is Metastatic or Cannot Be Removed by Surgery treatment 2 terminated NCT04388852
DS3201 and Ipilimumab for the Treatment of Metastatic Prostate, Urothelial and Renal Cell Cancers treatment 1 recruiting NCT02781506
Nivolumab and Stereotactic Ablative Radiation Therapy (SAbR) for Metastatic Clear Cell Renal Cell Carcinoma treatment 2 terminated NCT01510119
Autophagy Inhibition to Augment Mammilian Target of Rapamycin (mTOR) Inhibition: A Phase I/II Trial of RAD001 and Hydroxychloroquine (HCQ) in Patients With Previously Treated Renal Cell Carcinoma treatment 1 / 2 completed NCT06399419
CBM588 Capsules in Combination With Nivolumab and Ipilimumab for the Treatment of Advanced Stage Kidney Cancer treatment 1 recruiting NCT01391130
A Study of LY2510924 and Sunitinib in Patients With Metastatic Renal Cell Carcinoma treatment 2 terminated NCT05361720
Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study treatment 2 recruiting NCT03260504
Aldesleukin and Pembrolizumab in Treating Patients With Advanced or Metastatic Kidney Cancer treatment 1 terminated NCT05122546
CBM588 in Combination With Nivolumab and Cabozantinib for the Treatment of Advanced or Metastatic Kidney Cancer treatment 1 active_not_recruiting NCT02002312
Phase II Study of Lutetium-177 Labeled Girentuximab in Patients With Advanced Renal Cancer treatment 2 completed NCT03679767
A Study of INCMGA00012 in Participants With Selected Solid Tumors (POD1UM-203) treatment 2 completed NCT05782400
Multiomics Approach in Metastatic Clear Renal Cell Carcnoma No drug interventions Not Available Not Available recruiting NCT01793636
A Study Comparing AZD2014 vs Everolimus in Patients With Metastatic Renal Cancer treatment 2 terminated NCT01499121
Study of Efficacy and Safety of Sunitinib Given on an Individualized Schedule treatment 2 completed NCT05263050
Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors treatment 2 recruiting NCT06279403
Upfront Immune Checkpoint Inhibitors With Deferred Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma treatment 2 not_yet_recruiting NCT02228954
IMaging PAtients for Cancer Drug selecTion - Renal Cell Carcinoma (IMPACT-RCC) No drug interventions Not Available Not Available completed NCT02535351
Targeted Therapy With or Without Nephrectomy in Metastatic Renal Cell Carcinoma: Liquid Biopsy for Biomarkers Discovery treatment 3 terminated NCT05567588
Pembrolizumab Plus Radiotherapy for Advanced Renal Cancer treatment 2 recruiting NCT05745142
A Study to go Back Into Records and Observe How People With Metastatic Renal Cell Carcinoma (mRCC) Who Received a Medicine Called Sunitinib Responded to This Medicine. Not Available Not Available completed NCT02724020
MLN0128 and MLN0128 + MLN1117 Compared With Everolimus in the Treatment of Adults With Advanced or Metastatic Clear-Cell Renal Cell Carcinoma treatment 2 completed NCT02917772
Tailored ImmunoTherapy Approach With Nivolumab in Subjects With Metastatic or Advanced Renal Cell Carcinoma treatment 2 completed NCT02880943
Dose-finding, Safety and Efficacy Study of Radium-223 Dichloride (XOFIGO) in RCC Patients With Bone Metastases. (EIFFEL) treatment 1 / 2 unknown_status NCT02543645
A Study of Varlilumab and Atezolizumab in Patients With Advanced Cancer treatment 1 terminated NCT02386111
A Study of Varlilumab (Anti-CD27) and Sunitinib in Patients With Metastatic Clear Cell Renal Cell Carcinoma treatment 1 terminated NCT01521715
First Line Pazopanib in Poor Risk Patients With Metastatic Renal Cell Carcinoma treatment 4 completed NCT01715935
Biomarkers Before and After Nephrectomy of Locally Advanced or Metastatic Renal Cell Carcinoma Treated With Everolimus Not Available 2 completed NCT01693822
A Phase II Study of Axitinib in Patients With Metastatic Renal Cell Cancer Unsuitable for Nephrectomy treatment 2 completed NCT02570789
Evaluation of Predictive Markers for Toxicity and Efficacy in Patients With mccRCC Treated by Anti-VEGF Therapy basic_science 4 terminated NCT02978404
Combining Radiosurgery and Nivolumab in the Treatment of Brain Metastases treatment 2 completed NCT01472081
Nivolumab (BMS-936558; MDX-1106) in Combination With Sunitinib, Pazopanib, or Ipilimumab in Subjects With Metastatic Renal Cell Carcinoma (RCC) (CheckMate 016) treatment 1 completed